Navigation Links
“Provenge”, Dendritic cell vaccine for Prostate Cancr

An experimental dendritic vaccine has shown significant prognosis and extension of lifetime of men with prostate cancer. The vaccine Provenge is based on dendritic cells, which help the immune system recognize tumors. // “If these results are true, this represents the first proof of principle of a dendritic cell vaccine altering the natural history of a solid tumor”, says Philip Kantoff, Chief of solid tumor oncology at the Dana-Farber Cancer Institute in Boston.

Provenge carries the patients own dendritic cells engineered to express a protein found on about 95% of prostate cancer cells. It is one of more than 15 vaccines in trials for a range of cancers, including lymphoma, melanoma, breast, lung and colorectal cancers, but the first to increase lifespan in advancer cancer patients.

There are also questions about which cells are antigens to use in vaccines and the mode and frequency with which they should be administered. For example, mature dendritic cell vaccines seem to produce the best immune response when given either subcutaneously or intradermally, but not intravenously. Researchers are trying to determine whether vaccines will be need to be designed for specific cancers, or whether a universal vaccine could produce a robust immune response.

The provenge trial has raised several questions of its own: 34% of men given provenge, compared with 11% on placebo, were alive three years on, and lived 4.5 months on average longer. “Because of this, we were all somewhat pleasantly surprised that Provenge showed a survival benefit, says E. Roy Berger, director of the Prostate Cancer Consultation and Treatment service in East Setauket, New York.

“Cancer vaccines prime the immune system to attack cancer, a slower, more indirect process,’ he says. This may mean that survival, and not time to progression is a better measure of efficacy for cancer vaccines, Berger suggests.

Source: Nature Medcine

Page: 1

Related medicine news :

1. New hope for cancer victims – will vaccine cure the deadly bug
2. New vaccine helps allergy and asthma patients
3. Man against HIV – new vaccine ready for human trials
4. New vaccine helps allergy and asthma patients
5. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
6. HIV did not arise from polio vaccine
7. Double impact vaccine
8. High Demand for a child vaccine
9. A new vaccine for leukemia
10. Shortage of MMR vaccine
11. Anthrax vaccine produced
Post Your Comments:

(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, ... work on several important health care topics including advance care planning, healthcare costs ...
(Date:6/25/2016)... ... 25, 2016 , ... First Choice Emergency Room , the largest network ... the Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased ... location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/25/2016)... ... 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s ... setting the bar too high can result in disappointment, perhaps even self-loathing. However, those ... goal. , Research from reveals that behind the tendency to ...
(Date:6/24/2016)... ... , ... Marcy was in a crisis. Her son James, eight, was out of control. Prone ... physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If ... at my other children and say he was going to kill them. If we ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016 Dublin ... addition of the " Global Markets for Spectroscopy ... This report focuses on the ... review, including its applications in various applications. The report ... includes three main industries: pharmaceutical and biotechnology, food and ...
(Date:6/24/2016)... Research and Markets has announced the ... Tests" report to their offering. ... The World Market for Companion Diagnostics covers the ... analysis in the report includes the following: ... Kits) by Region (N. America, EU, ROW), 2015-2020 , ...
(Date:6/23/2016)... HOUSTON , June 23, 2016  MedSource ... platform as its e-clinical software solution of choice.  ... the best possible value to their clients by ... nowEDC.  The preferred relationship establishes nowEDC as the ... pricing for MedSource,s full-service clients.  "nowEDC has long ...
Breaking Medicine Technology: